CD200R1 and head and neck squamous cell carcinoma: Recently, mice transplanted with head and neck squamous cell carcinoma (HNSCC) cells overexpressing CD200 exhibited attenuated tumor growth when treated with adenovirus-expressing soluble CD200R-Ig [146].